Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BHP Billiton Limited (BHP) vs TransMedics Group Inc (TMDX) Price & Performance

BHP Billiton LimitedTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

BHP Billiton Limited vs TransMedics Group Inc — how do they compare? BHP Billiton Limited trades at $90.51 (market cap $229.15B), while TransMedics Group Inc trades at $87.25 (market cap $3.10B). The key difference: BHP Billiton Limited is far larger — about 73.9× TransMedics Group Inc's market cap, and BHP Billiton Limited pays a 2.95% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

BHPTMDX
Market Cap
$229.15B$3.10B
Sector
Basic MaterialsTechnology
52-Week High
$93.15$150.42
52-Week Low
$52.14$61.99
Enterprise Value
$243.35B$3.49B
Dividend Yield
2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BHP Billiton Limited

BHP trades at $90.38, down 0.25% on the day, with a bullish technical signal driven by moving averages. The company reported Q4 2025 EPS of $2.24, missing expectations of $2.41, but maintains strong profitability with an 18.97% net income margin. Recent news highlights labor strikes at Port Hedland iron ore operations, potentially impacting production, while institutional buying activity signals confidence.

Outlook is mixed: solid fundamentals and copper demand from AI data centers offer growth potential, but strikes and valuation concerns pose risks. Analysts are cautious with 64.52% hold ratings, reflecting balanced near-term uncertainty amid long-term resource strengths.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $87.42, down 1.12% on the day, with a bullish technical outlook from moving averages but bearish oscillators signaling potential overbought conditions. The company reported mixed Q2 2026 results, missing earnings estimates with EPS of $0.44 versus $0.50 expected, while revenue growth remains robust. Recent news highlights an ongoing investigation into fiduciary duties by directors, adding uncertainty.

The stock presents a cautious opportunity with strong analyst support (69% buy ratings) and a consensus price target of $99.57, implying upside, but risks include earnings volatility, margin pressures, and legal scrutiny. Fundamentals show solid profitability with a 22.69% net margin, though valuation multiples like P/E of 23.15 suggest premium pricing relative to historical norms.

Returns comparison

Trailing returns across standard periods

About BHP Billiton Limited

BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.

Read more on BHP

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX